BIO-RAD LABORATORIES, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
BIO-RAD LABORATORIES, INC. (BIO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $31.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $31.40M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33.20M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $35.20M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $38.10M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $31.40M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $33.20M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $35.20M 10-K · filed 2026-02-13 |
| 2025-09-30 | $38.10M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $37.30M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $21.20M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $22.40M 10-K · filed 2025-02-14 |
| 2024-09-30 | $25.50M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $26.30M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $29.20M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $30.40M 10-K · filed 2024-02-16 |
| 2023-09-30 | $30.80M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $22.80M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $22.70M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $26.50M 10-K · filed 2023-02-17 |
| 2022-09-30 | $24.30M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $26.50M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $28.50M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $34.50M 10-K · filed 2022-02-11 |
| 2021-09-30 | $39.10M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $37.40M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $38.80M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $41.30M 10-K · filed 2021-02-16 |
| 2020-09-30 | $44.20M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $42.10M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $44.00M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $44.00M 10-K · filed 2020-03-02 |
| 2019-09-30 | $54.70M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $53.90M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $57.30M 10-Q · filed 2019-05-10 |